Surgical audience focused on multimodality treatment for lung cancer.

Interdiscip Cardiovasc Thorac Surg · 2025 · PMC12237512 · PMID 40628491

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Interestingly, at 4-year follow-up, OS was not reached in both arms, but a positive trend was in favour of nivolumab (4-year OS rate 71% versus 58%), especially for the patients obtaining a pCR (HR 0.08, 95% CI 0.02–0.34) [ 8 ].

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.